Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 79(17):e263–e421. https://doi.org/10.1016/j.jacc.2021.12.012
Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, Cook NR, Felker GM, Francis GS, Hauptman PJ, Havranek EP, Krumholz HM, Mancini D, Riegel B, Spertus JA; American Heart Association; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia (2012) Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 125(15):1928-52. https://doi.org/10.1161/CIR.0b013e31824f2173
Hawkins NM, Bennett MT, Andrade JG, Virani SA, Krahn AD, Ignaszewski A, Toma M (2015) Review of eligibility for cardiac resynchronization therapy. Am J Cardiol. 116(2):318–24. https://doi.org/10.1016/j.amjcard.2015.04.026
Salah HM, Goldberg LR, Molinger J, Felker GM, Applefeld W, Rassaf T, Tedford RJ, Mirro M, Cleland JGF, Fudim M (2022) Diaphragmatic function in cardiovascular disease JACC Review Topic of the Week. J Am Coll Cardiol. 80(17):1647–1659
Article CAS PubMed Google Scholar
Fudim M, Mirro M, Goldberg LR (2022) Synchronized diaphragmatic stimulation for the treatment of symptomatic heart failure: a novel implantable therapy concept. JACC BTS 7(3):322–323
Jorbenadze A, Young R, Shaburishvili T, Demyanchuk V, Buriak V, Todurov B, Rudenko K, Zuber M, Stämpfli SF, Tanner FC, Erne P, Mirro M, Fudim M, Goldberg LR, Cleland JGF (2022) Synchronized diaphragmatic stimulation for heart failure using the VisONE system: a first-in-patient study. ESC Heart Fail. 9(4):2207–2214. https://doi.org/10.1002/ehf2.13984
Jorbenadze A, Goldberg LR, Shaburishvili T, Zuber M, Mirro M, Fudim M (2022) Synchronized diaphragmatic stimulation for heart failure with a reduced left ventricular ejection fraction using the VisONE system: a first-in-patient study with extended population. Struct Heart. 6(6):100103. https://doi.org/10.1016/j.shj.2022.100103
Article PubMed PubMed Central Google Scholar
Fudim M, Becker G, Shaburishvili T, Chiabrishvili D, Zirakashvili T, Oniani B, Shaishmelashvili G, Mirro M, Goldberg L (2025) RECOVER-HF Pilot Study: synchronized diaphragmatic stimulation for HFrEF therapy. Presented at THT
Hayes DL, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Seth M, Jones PW, Saxon LA (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 8(9):1469–75
Denfeld QE, Jha SR, Fung E, Jaarsma T, Maurer MS, Reeves GR, Afilalo J, Beerli N, Bellumkonda L, De Geest S, Gorodeski EZ, Joyce E, Kobashigawa J, Mauthner O, McDonagh J, Uchmanowicz I, Dickson VV, Lindenfeld J, Macdonald P (2023) Assessing and managing frailty in advanced heart failure: an International Society for Heart and Lung Transplantation consensus statement. J Heart Lung Transplant. S1053–2498(23):02028–4. https://doi.org/10.1016/j.healun.2023.09.013
Sokos G, Kido K, Panjrath G et al (2023) (2023) Multidisciplinary care in heart failure services. J Card Fail 29(6):943–958. https://doi.org/10.1016/j.cardfail.2023.02.011
Sokos G, Kido K, Panjrath G, Benton , Page R, Patel J, Smith PJ, Korous S, Guglin M (2018) Multidisciplinary team approach to heart failure management. Heart 104(16), 1376
Bauer P, Snell J, Wheeler T, Chinchoy E, Mirro M (2017) Animal model of diaphragmatic stimulation effects on cardiovascular function. Presented at HFSA Abstract 335
Beeler R, Schoenenberger A, Zuber M, Bauer P, Erne S, Schlaepfer R, Erne P (2017) Sustained improvements to ventricular function due to asymptomatic diaphragmatic stimulation. Presented at HFSA 2017, Abstract 337
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Böhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F. EMPEROR-Reduced Trial Investigators (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 383(15):1413-1424. https://doi.org/10.1056/NEJMoa2022190
Pipilas DC, Hanley A, Singh JP, Mela T (2023) Cardiac contractility modulation for heart failure: current and future directions. J Soc Cardiovasc Angiogr Interv. 2(6):101176. https://doi.org/10.1016/j.jscai.2023.101176
Article PubMed PubMed Central Google Scholar
Hoppe UC, Brandt MC, Wachter R, Beige J, Rump LC, Kroon AA, Cates AW, Lovett EG, Haller H (2012) Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens. 6(4):270–6. https://doi.org/10.1016/j.jash.2012.04.004
Comments (0)